IGF2BP3 and acute myeloid leukemia: We compared the expression of these genes in AML patients versus healthy samples using the TNM database [42], and noted that PLCH1, ZBED3, IGF2BP3, INSM1, and SLC17A8 were elevated in leukemic patients in comparison to healthy samples (Fig. 4D).